CREDIT SUISSE AG/ - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 85 filers reported holding ENZO BIOCHEM INC in Q4 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.3%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q4 2020$32,000
+14.3%
12,664
-2.0%
0.00%
Q3 2020$28,000
-42.9%
12,918
-5.5%
0.00%
Q3 2019$49,000
-2.0%
13,672
-7.6%
0.00%
Q2 2019$50,000
+85.2%
14,792
+46.0%
0.00%
Q1 2019$27,000
-59.1%
10,129
-21.4%
0.00%
Q2 2018$66,000
-52.5%
12,887
-49.2%
0.00%
Q1 2018$139,000
+26.4%
25,357
+88.9%
0.00%
Q4 2017$110,000
-67.1%
13,421
-58.0%
0.00%
Q3 2017$334,000
+70.4%
31,942
+13.3%
0.00%
Q4 2016$196,000
+145.0%
28,192
+78.7%
0.00%
Q3 2016$80,000
-25.9%
15,776
-12.7%
0.00%
Q2 2016$108,000
-73.9%
18,073
-80.1%
0.00%
Q1 2016$414,000
+187.5%
90,949
+184.5%
0.00%
Q4 2015$144,000
+1.4%
31,969
-31.8%
0.00%
Q2 2015$142,000
+86.8%
46,845
+173.5%
0.00%
Q4 2014$76,000
-55.0%
17,131
-47.9%
0.00%
Q3 2014$169,000
-23.9%
32,878
-22.3%
0.00%
Q2 2014$222,000
+344.0%
42,319
+75.9%
0.00%
Q2 2013$50,00024,0550.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q4 2020
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,392,642$6,939,00011.21%
VIEX Capital Advisors, LLC 1,435,130$4,162,0007.44%
HARBERT FUND ADVISORS, INC. 5,175,913$15,010,0006.29%
Potomac Capital Management, Inc. 496,805$1,441,0001.24%
AMH Equity Ltd 30,000$87,0000.09%
Corsair Capital Management 75,026$218,0000.05%
RBF Capital, LLC 250,359$730,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$74,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 539,954$1,566,0000.04%
Cutter & CO Brokerage, Inc. 25,777$75,0000.02%
View complete list of ENZO BIOCHEM INC shareholders